Published in Cell Mol Life Sci on November 01, 2006
Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell (2008) 2.32
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J (2008) 2.03
Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis (2010) 1.85
Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J Clin Invest (2011) 1.79
Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci (2013) 1.77
Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci (2008) 1.59
CAG repeats mimic CUG repeats in the misregulation of alternative splicing. Nucleic Acids Res (2011) 1.42
Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev (2009) 1.37
Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener (2006) 1.35
Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 1.25
Mitotic spindle (DIS)orientation and DISease: cause or consequence? J Cell Biol (2012) 1.21
Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease. EMBO J (2010) 1.19
Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res (2011) 1.17
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta (2011) 1.16
A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet (2013) 1.13
The insulin-like growth factor pathway is altered in spinocerebellar ataxia type 1 and type 7. Proc Natl Acad Sci U S A (2008) 1.11
Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience (2008) 1.08
Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet (2010) 1.06
Wild-type HTT modulates the enzymatic activity of the neuronal palmitoyl transferase HIP14. Hum Mol Genet (2011) 1.05
Co-clustering phenome-genome for phenotype classification and disease gene discovery. Nucleic Acids Res (2012) 1.05
Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA. Ann N Y Acad Sci (2009) 1.05
HD CAG-correlated gene expression changes support a simple dominant gain of function. Hum Mol Genet (2011) 1.04
Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol (2011) 1.00
pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. Mol Brain (2010) 1.00
Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Mol Brain (2009) 0.96
Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases. Brain Res Rev (2008) 0.96
Mechanism of cis-inhibition of polyQ fibrillation by polyP: PPII oligomers and the hydrophobic effect. Biophys J (2009) 0.95
Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulation. EMBO J (2015) 0.95
Huntingtin mediates dendritic transport of β-actin mRNA in rat neurons. Sci Rep (2011) 0.92
The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling. EMBO Mol Med (2013) 0.91
The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Curr Trends Neurol (2011) 0.90
BDNF signaling and survival of striatal neurons. Front Cell Neurosci (2014) 0.90
Proteasomes cleave at multiple sites within polyglutamine tracts: activation by PA28gamma(K188E). J Biol Chem (2008) 0.90
Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells. Mol Cell Neurosci (2008) 0.86
Huntington's Disease and Striatal Signaling. Front Neuroanat (2011) 0.86
Synaptic mutant huntingtin inhibits synapsin-1 phosphorylation and causes neurological symptoms. J Cell Biol (2013) 0.86
Huntingtin's function in axonal transport is conserved in Drosophila melanogaster. PLoS One (2013) 0.85
A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease. J Biol Chem (2014) 0.84
Sirt1's complex roles in neuroprotection. Cell Mol Neurobiol (2009) 0.84
Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells. J Neural Transm (Vienna) (2011) 0.83
Dysfunctional mitochondrial respiration in the striatum of the Huntington's disease transgenic R6/2 mouse model. PLoS Curr (2013) 0.83
Loss of Ahi1 affects early development by impairing BM88/Cend1-mediated neuronal differentiation. J Neurosci (2013) 0.82
Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease. Hum Mol Genet (2015) 0.82
Deletion of the huntingtin proline-rich region does not significantly affect normal huntingtin function in mice. J Huntingtons Dis (2012) 0.82
Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay. Neurobiol Dis (2011) 0.82
A folded and functional protein domain in an amyloid-like fibril. Protein Sci (2008) 0.82
Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. PLoS One (2014) 0.81
Mass spectrometric identification of novel lysine acetylation sites in huntingtin. Mol Cell Proteomics (2011) 0.81
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Front Cell Neurosci (2014) 0.81
Scalable production in human cells and biochemical characterization of full-length normal and mutant huntingtin. PLoS One (2015) 0.80
Directed PCR-free engineering of highly repetitive DNA sequences. BMC Biotechnol (2011) 0.80
Loss of huntingtin-associated protein 1 impairs insulin secretion from pancreatic β-cells. Cell Mol Life Sci (2011) 0.79
ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line. Brain Res (2009) 0.78
Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane. Dis Model Mech (2014) 0.77
Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease. Hum Mol Genet (2016) 0.77
Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease. J Huntingtons Dis (2012) 0.76
Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding. Biophys J (2016) 0.76
The emerging role of the first 17 amino acids of huntingtin in Huntington's disease. Biomol Concepts (2015) 0.76
Serine 421 regulates mutant huntingtin toxicity and clearance in mice. J Clin Invest (2016) 0.76
Studying polyglutamine diseases in Drosophila. Exp Neurol (2015) 0.76
Transgenic rat model of Huntington's disease: a histopathological study and correlations with neurodegenerative process in the brain of HD patients. Biomed Res Int (2014) 0.75
Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology. Front Aging Neurosci (2017) 0.75
PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model. Front Cell Neurosci (2017) 0.75
DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science (1993) 9.94
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet (1996) 3.26
Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature (1995) 2.92
Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron (2000) 2.82
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet (1997) 2.77
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet (1995) 2.33
p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci (2001) 1.87
Notification of hepatitis A. BMJ (1991) 1.81
Cloning of the 62-kilodalton component of basic transcription factor BTF2. Science (1992) 1.74
Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol (1998) 1.61
Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH). EMBO J (1994) 1.60
Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers. Proc Natl Acad Sci U S A (1992) 1.32
Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci (1998) 1.24
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet (1997) 1.24
The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2/TFIIH. J Biol Chem (1994) 1.11
Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci (1998) 1.09
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol Dis (2001) 1.07
Partial characterization of the DNA repair protein complex, containing the ERCC1, ERCC4, ERCC11 and XPF correcting activities. Mutat Res (1995) 0.99
Outcomes of children with abdominal compartment syndrome. Acta Clin Belg Suppl (2007) 0.90
5-HT1B receptor knock out--behavioral consequences. Behav Brain Res (1996) 0.89
Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Hum Mol Genet (1996) 0.87
Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic? Pathol Biol (Paris) (2004) 0.82
[Use of the Airtraq by inexperienced physicians supervised during a series of tracheal intubation in adult patient with anticipated difficult airway]. Ann Fr Anesth Reanim (2011) 0.78
Differential distribution of the normal and mutated forms of huntingtin in the human brain. Ann Neurol (1997) 0.78
Behavioral characterization of mice packing the 5-HT1B receptor. NIDA Res Monogr (1996) 0.78
Outcomes of children with abdominal compartment syndrome. Acta Clin Belg (2007) 0.75
Meningococcal conjunctivitis. Eye (Lond) (1990) 0.75
Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides. Anal Biochem (1993) 0.75